← Organogenesis Holdings Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $193.4m |
$261.0m
+34.91%
|
$338.3m
+29.63%
|
$468.1m
+38.36%
|
$450.9m
-3.67%
|
$433.1m
-3.94%
|
$482.0m
+11.29%
|
$564.2m
+17.04%
|
$454.6m
-19.42%
|
|
| Cost of Goods and Services Sold | $48.2m |
$61.2m
+27.01%
|
$68.8m
+12.39%
|
$75.9m
+10.38%
|
$87.3m
+14.97%
|
$114.2m
+30.78%
|
$105.0m
-8.04%
|
$106.5m
+1.39%
|
$115.7m
+8.70%
|
$137.5m
+18.82%
|
$135.6m
-1.39%
|
|
| Gross Profit | ($48.2m) |
($61.2m)
-27.01%
|
$124.6m
+303.60%
|
$185.0m
+48.45%
|
$251.0m
+35.64%
|
$353.9m
+40.99%
|
$345.9m
-2.26%
|
$326.7m
-5.56%
|
$366.3m
+12.14%
|
$426.6m
+16.47%
|
$319.0m
-25.23%
|
|
| Research and Development Expense | — | — | $10.7m | $14.8m | $20.1m | $30.7m | $39.8m | $44.4m | $50.3m | $44.5m | $57.0m | |
| Selling, General and Administrative Expense | $93.0m | $133.7m | $162.0m | $199.7m | $203.5m | $250.2m | $283.8m | $269.8m | $294.5m | $326.2m | $299.1m | |
| Amortization of Intangible Assets | — | — | $3.7m | $6.0m | $3.7m | $4.9m | $4.9m | $4.9m | $3.4m | $3.3m | — | |
| Operating Lease, Expense | — | — | $2.8m | $6.2m | $6.5m | — | — | — | — | — | — | |
| Operating Costs and Expenses | — | — | — | — | — | — | — | — | — | $137.5m | — | |
| Operating Expenses | $209k | $4.6m | $176.2m | $214.5m | $223.6m | $280.9m | $323.6m | $314.1m | $367.6m | $519.5m | $488.8m | |
| Operating Income (Loss) | $209k |
($4.6m)
-2300.23%
|
($51.6m)
-1022.78%
|
($29.5m)
+42.86%
|
$27.4m
+193.06%
|
$72.9m
+165.98%
|
$22.3m
-69.41%
|
$12.5m
-43.84%
|
($1.3m)
-110.24%
|
$44.7m
+3583.55%
|
($34.2m)
-176.50%
|
|
| Interest Expense | — | — | $10.9m | $9.0m | $11.3m | $7.2m | $2.0m | $2.2m | — | — | $1.5m | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | $2.2m | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | $162k | $13k | $97k | ($13k) | ($13k) | $57k | $20k | ($5k) | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $1.5m | ($2.3m) | $1.5m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $209k | $4.6m | ($64.7m) | ($40.3m) | $18.5m | $63.8m | $20.3m | $10.4m | ($2.8m) | $47.0m | ($34.8m) | |
| Current Income Tax Expense (Benefit) | $65k | $7.0m | ($102k) | $39k | $418k | $860k | $2.8m | $3.4m | $7.1m | $438k | $49.4m | |
| Income Tax Expense (Benefit) | $65k | $7.0m | $84k | $150k | $530k | ($31.1m) | $4.8m | $5.4m | ($3.7m) | $9.9m | $49.4m | |
| Net Income (Loss) Attributable to Parent | ($209k) |
($2.1m)
-903.32%
|
($64.8m)
-2996.16%
|
($40.5m)
+37.60%
|
$17.9m
+144.37%
|
$94.9m
+428.73%
|
$15.5m
-83.63%
|
$4.9m
-68.16%
|
$861k
-82.59%
|
$37.0m
+4201.05%
|
($101.7m)
-374.58%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | — | ($4.4m) |
($64.8m)
-1361.45%
|
($41.1m)
+36.61%
|
$17.9m
+143.67%
|
$94.9m
+428.73%
|
$15.5m
-83.63%
|
$4.9m
-68.16%
|
($937k)
-118.95%
|
$20.0m
+2236.82%
|
($101.7m)
-607.86%
|
|
| Preferred Stock Dividends, Income Statement Impact | — | — | — | — | — | — | — | — | $1.4m | $10.8m | $11.3m | |
| Earnings Per Share, Basic | — | — | ($0.94) | ($0.44) | $0.17 | $0.74 | $0.12 | $0.04 | ($0.01) | $0.16 | ($0.78) | |
| Earnings Per Share, Diluted | ($0.03) | ($0.48) | ($0.94) | ($0.44) | $0.16 | $0.71 | $0.12 | $0.04 | ($0.01) | $0.15 | ($0.79) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 107.7m | 128.3m | 130.1m | 131.2m | 131.7m | 126.7m | 127.6m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | 111.4m | 133.7m | 132.4m | 132.7m | 131.7m | 130.2m | 131.1m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $1.7m |